Rodríguez-Vélez R, Ortiz-Rivera OJ, Bower B, Gorowski K, Windemuth A, Villagra D, et al. Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction with Genotype-guided Warfarin (Coumadin®) Dosing. PRHSJ [Internet]. 2010 Nov. 18 [cited 2025 Oct. 25];29(4). Available from: https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/440